Hematopoietic progenitor cell mobilization with “just-in-time” plerixafor approach is a cost-effective alternative to routine plerixafor use

Autor:	Veltri, Lauren 1, Cumpston, Aaron 2, Shillingburg, Alexandra 2, Wen, Sijin 3, Luo, Jin 3, Leadmon, Sonia 4, Watkins, Kathy 4, Craig, Michael 4, Hamadani, Mehdi 5, Kanate, Abraham S. 4, ∗
Zdroj:	In Cytotherapy December 2015 17(12):1785-1792
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect